Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79676 - 79700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Titanium dioxide	Approved	FLRT2	23768	upregulated	titanium dioxide results in increased expression of FLRT2 mRNA	14q31.3	A24434
Titanium dioxide	Approved	FLRT3	23767	upregulated	titanium dioxide results in increased expression of FLRT3 mRNA	20p12.1	A24434
Titanium dioxide	Approved	FN1	2335	upregulated	titanium dioxide results in increased expression of FN1 mRNA	2q35	A24434 A24217
Titanium dioxide	Approved	G6PD	2539	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of G6PD mRNA	Xq28	A24432
Titanium dioxide	Approved	GADD45A	1647	upregulated	titanium dioxide results in increased expression of GADD45A mRNA	1p31.3	A24437
Titanium dioxide	Approved	GDF15	9518	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of GDF15 mRNA	19p13.11	A24432
Titanium dioxide	Approved	GJA5	2702	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of GJA5 mRNA	1q21.2	A24432
Titanium dioxide	Approved	GOT1	2805	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of GOT1 mRNA	10q24.2	A24432
Titanium dioxide	Approved	HAPLN4	404037	upregulated	titanium dioxide results in increased expression of HAPLN4 mRNA	19p13.11	A24434
Titanium dioxide	Approved	HMOX1	3162	downregulated	titanium dioxide results in decreased expression of HMOX1 mRNA	22q12.3	A24434 A24217
Titanium dioxide	Approved	HMOX1	3162	upregulated	titanium dioxide results in increased expression of HMOX1 mRNA	22q12.3	A24439
Titanium dioxide	Approved	HMOX1	3162	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of HMOX1 mRNA	22q12.3	A24432
Titanium dioxide	Approved	HMOX2	3163	upregulated	titanium dioxide results in increased expression of HMOX2 mRNA	16p13.3	A24434
Titanium dioxide	Approved	HSPA4	3308	downregulated	titanium dioxide results in decreased expression of HSPA4 mRNA	5q31.1	A24434
Titanium dioxide	Approved	HSPA6	3310	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of HSPA6 mRNA	1q23.3	A24432
Titanium dioxide	Approved	IBSP	3381	upregulated	titanium dioxide results in increased expression of IBSP mRNA	4q22.1	A20622
Titanium dioxide	Approved	ID1	3397	downregulated	titanium dioxide results in decreased expression of ID1 mRNA	20q11.21	A24433
Titanium dioxide	Approved	ID3	3399	downregulated	titanium dioxide results in decreased expression of ID3 mRNA	1p36.12	A24433
Titanium dioxide	Approved	IFNA1	3439	upregulated	titanium dioxide results in increased expression of IFNA1 mRNA	9p21.3	A24217
Titanium dioxide	Approved	IFNGR1	3459	upregulated	titanium dioxide results in increased expression of IFNGR1 mRNA	6q23.3	A24217
Titanium dioxide	Approved	IFNGR2	3460	upregulated	titanium dioxide results in increased expression of IFNGR2 mRNA	21q22.11	A24217
Titanium dioxide	Approved	IKBKB	3551	upregulated	titanium dioxide results in increased expression of IKBKB mRNA	8p11.21	A24217
Titanium dioxide	Approved	IL10	3586	upregulated	titanium dioxide results in increased expression of IL10 mRNA	1q32.1	A24217
Titanium dioxide	Approved	IL12A	3592	upregulated	titanium dioxide results in increased expression of IL12A mRNA	3q25.33	A24434
Titanium dioxide	Approved	IL13	3596	upregulated	titanium dioxide results in increased expression of IL13 mRNA	5q31.1	A24434

Displaying entries 79676 - 79700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability